EssilorLuxottica Books Continued Sales Growth as AI Glasses Keep Momentum
By Joshua Kirby
EssilorLuxottica said sales continued to rise apace in the first quarter of the year, boosted by demand for the artificial-intelligence-powered glasses that the company hopes will fuel growth over the coming years.
The Franco-Italian eyecare behemoth made revenue of 7.13 billion euros ($8.37 billion) between January and March, it said Wednesday. That marks an 11% rise from the same period last year, adjusted for currency effects. The result was in line with the expectations of analysts polled by Visible Alpha ahead of the release.
The group--which has flagged surging demand for the AI-powered eyewear it manufactures in tandem with tech giant Meta--said smartglasses helped drive its sales over the quarter. EssilorLuxottica and Meta earlier this year launched a new Ray-Ban model aimed at wearers of prescription lenses.
The group last year sold more than 7 million pairs of smartglasses, and earlier this year said demand for the wearable tech should ensure "solid growth" in its top line over the years ahead.
"Momentum is reflected in the continued robust traction of our myopia management platform and in the strong results delivered by wearables," said Francesco Milleri, the group's chief executive, and Paul du Saillant, its deputy CEO.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
April 22, 2026 12:32 ET (16:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States